Article
Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.
PloS one - 1 Jan 2014
Sode Jacob, Vogel Ulla, Bank Steffen, Andersen Paal Skytt, Thomsen Marianne Kragh, Hetland Merete Lund, Locht Henning, Heegaard Niels H H, Andersen Vibeke
Abstract excerpt
OBJECTIVE: Many patients with rheumatoid arthritis (RA) benefit from tumor necrosis factor-α blocking treatment (anti-TNF), but about one third do not respond. The objective of this study was to replicate and extend previously found associations between anti-TNF treatment response and genetic variation in the TNF-, NF-κB- and pattern recognition receptor signalling pathways. METHODS: Forty-one single nucleotide...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
